Infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: All patients, with or without suppuration, receive estradiol orally at a dose of 4-6 mg from the second or third day of the menstrual cycle, and after transvaginal
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: • Candidate patients for embryo transfer between 20 and 45 years old • Patients with at least two good quality embryos for transfer • Patients with normal BMI • Patients with a healthy uterine cavity confirmed by hysterosalpingograph and hysteroscope or ultrasound.
Exclusion criteria
Exclusion criteria: • Patients with uncontrolled chronic disease • Patients with donated eggs or embryos • Patients with surrogacy • Poor responder • Patients with endometriosis problems • Non-use or irregular use of medicines • Patients with a history of more than three unsuccessful transplants (RIF) • Presence of hydrosalpinx • Patients with endometrial thickness less than 7 mm after HRT • Patients with adenomyosis • Patients whose embryos are the result of TESE or severe male factor • PGD candidate patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy rates. Timepoint: 2 weeks and 6 weeks after embryo transfer. Method of measurement: Through B-HCG test and transvaginal ultrasound.;Clinical pregnancy rate. Timepoint: 2 weeks and 6 weeks after embryo transfer. Method of measurement: Through B-HCG test and transvaginal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: By transvaginl sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmeneh Keshavarzi
Shiraz University of Medical Sciences
Outcome results
None listed